Here’s why I’d forget about the Fevertree Drinks share price ‘fad’

Fevertree Drinks (LON: FEVR) has had a poorer 2019 than it expected, but could 2020 be even worse?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

In my early investing days, I learned a lot from a Motley Fool colleague who had the knack of identifying what he called ‘fad’ stocks. They’re stocks that capture the mood of the moment, a passing fashion… but typically boom and then bust.

Perhaps they’re selling a new product that’s doing the rounds among young people. Or maybe a company is just making a big deal out of nothing special and advertising it big.

A what specialist?

Today, I’m examining Fevertree Drinks (LSE: FEVR), whose share price boomed in 2018. When I first saw Fevertree described as a tonic water specialist, my fad alert started sounding loudly in my head.

We’ve had all kinds of booze fads in recent years. Does anyone remember alcopops? Or beer with lemon stuck in the neck of the bottle? Or ready-made cocktails? Whenever I look at the supermarket booze section these days, I see more flavoured gins than just about anything else. But that’s a fad, and it will pass.

Now, Fevertree makes more than just fancy tonic waters, it does all sorts of mixers too. But tonic waters do seem to dominate. A quick check on the firm’s products reveals Elderflower tonic water, Aromatic tonic water, Clementine & Cinnamon tonic water… and many more.

I suspect there probably is a longer-term market for fancy mixer drinks, but not as big as hopeful growth investors think. It’s a market that’s very easy to get into too, and I don’t really see how Fevertree has any kind of protective moat or competitive advantage.

Competition

In my search for Fevertree products, I found ‘botanical brewery’ Fentimans offering Botanical, Pink Grapefruit, Mediterranean Orange, and even Connoisseur tonic waters. Then I found Double Dutch brand Cucumber and Watermelon tonic water.

The big names, like Coca-Cola and Schweppes are getting in on the act too — fancy some Russchian Aromatic Citrus tonic water? And then the big supermarkets, like Tesco, are offering their own brands.

I reckon the young people buying all this stuff in the bars probably won’t even know who makes their mixers. Just as long as they can be seen drinking their fashionable, I don’t know, South Seas Tulip tonic water or whatever, I can’t see them caring. People will just buy whatever the bar happens to stock. Until the ‘fancy mixers’ fad is over.

Shares?

So that’s my take on the products — probably decent enough, but probably set to go the way of all those previous drinking fads. But what about Fevertree Drinks shares?

The share price is way down from its peak, suffering an extra crunch when the firm’s latest year-end trading update was released. On 20 January, Fevertree shares lost more than a quarter of their value in just the one day. The update confirmed all my worst fears about rising competition.

Even after that dip, we’re still looking at a forward P/E of probably about 28 — around twice the FTSE 100‘s long-term average. I think Fevertree is still an overpriced fad stock.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has recommended Tesco. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Black woman using a debit card at an ATM to withdraw money
Investing Articles

Meet the FTSE 100’s newest bank stock

This FTSE 250 stock has skyrocketed nearly 900% over the past 60 months, earning it a place in the prestigious…

Read more »

Investing Articles

See what £10,000 invested in Shell shares 1 month ago is worth now

Harvey Jones looks at how Shell shares have fared over the past month and more importantly, what the long-term outlook…

Read more »

Finger clicking a button marked 'Buy' on a keyboard
Growth Shares

At its lowest level since July, here’s why I think the IAG share price is dead cheap

Jon Smith explains why the IAG share price has fallen over the past week but talks through the reasons why…

Read more »

Picture of an easyJet plane taking off.
Investing Articles

Will the easyJet share price rise 43% or 97% by this time next year?

City analysts believe easyJet's share price might almost double over the next year. Royston Wild considers the outlook for the…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

More great news for Rolls-Royce shares!

Rolls-Royce shares got a boost this week after some intriguing developments in the process of creating Europe's new fighter aircraft.

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

Persimmon’s share price surges 7% on double boost! Can it keep rising?

Persimmon's share price is surging, up 11% at one point earlier on Tuesday. Could this be the start of a…

Read more »

This way, That way, The other way - pointing in different directions
Investing Articles

What on earth’s happening to the Greggs share price?

Harvey Jones says Greggs’ share price has shown surprising resilience in the recent stock market turmoil, but the FTSE 250…

Read more »

Mature black woman at home texting on her cell phone while sitting on the couch
Investing Articles

Barclays shares are down 18%. Time to consider buying?

Barclays’ shares have plummeted in recent weeks. Edward Sheldon looks at what’s going on and provides his view on the…

Read more »